Health Highlights: April 1, 201304/01/13
Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Novartis Loses Cancer Drug Patent Fight in India
Swiss drug maker Novartis AG's attempt to patent an updated
version of its cancer drug Glivec was rejected Monday by India's
Health activists said the decision ensures that poor patients
worldwide will continue to have access to cheap versions of
lifesaving medicines, the
Glivec, which is known as Gleevec outside of India and Europe,
is mainly used to treat leukemia.
Indian generic drug maker Cipla makes a version of Glivec that
sells for less than a tenth of the original drug's selling price,
Bird Flu Kills Two in China
Two men in Shanghai, China have died from a strain of bird flu
not previously found in people.
The men, ages 27 and 87, became sick after contracting the H7N9
strain in February. A 35-year-old woman in the city of Chuzhou, in
neighboring Anhui Province, was also infected with the strain and
is critically ill, according to the official Chinese news agency
The New York Timesreported.
It's unclear how the three become infected. All three showed
initial symptoms of coughing and fever, which later developed into
difficulty breathing and pneumonia, said China's National Health
and Family Planning Commission.
Officials said the three patients had not had mutual contact and
dozens of people who had contact with them did not appear to be
infected with the H7N9 strain of bird flu.
Since 2003, the H5N1 strain of bird flu has killed hundreds of
Copyright © 2013
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.